Early dual antiplatelet therapy in stroke: should we take the CHANCE?
作者信息
Brandler Ethan S, Sharma Mohit
机构信息
1 Department of Emergency Medicine, Associate Director, Emergency Medical Services, State University of New York at Stony Brook, NY, USA ; 2 Department of Community Medicine, Government Medical College and Guru Nanak Dev Hospital, Amritsar 143001, India.
出版信息
Ann Transl Med. 2015 Aug;3(13):177. doi: 10.3978/j.issn.2305-5839.2015.07.23.
Abstract
摘要
相似文献
1
Early dual antiplatelet therapy in stroke: should we take the CHANCE?卒中早期双重抗血小板治疗：我们应该把握CHANCE时机吗？
Ann Transl Med. 2015 Aug;3(13):177. doi: 10.3978/j.issn.2305-5839.2015.07.23.
2
When a Single Antiplatelet Agent for Stroke Prevention Is Not Enough: Current Evidence and Future Applications of Dual Antiplatelet Therapy.当单一抗血小板药物预防卒中不足时：双重抗血小板治疗的当前证据与未来应用
Curr Treat Options Cardiovasc Med. 2016 Apr;18(4):26. doi: 10.1007/s11936-016-0449-7.
3
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.缺血性脑卒中患者长期双联与单联抗血小板治疗的获益-风险特征：系统评价和荟萃分析。
Ann Intern Med. 2013 Oct 1;159(7):463-70. doi: 10.7326/0003-4819-159-7-201310010-00006.
4
Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients.不同血压水平的小卒中或 TIA 患者，接受双联抗血小板治疗获益不同。
Sci Rep. 2017 Jun 20;7(1):3884. doi: 10.1038/s41598-017-04169-8.
5
Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial.短暂性脑缺血发作和小卒中伴不同梗死模式的双联抗血小板治疗：CHANCE 随机临床试验的亚组分析。
JAMA Neurol. 2018 Jun 1;75(6):711-719. doi: 10.1001/jamaneurol.2018.0247.
6
Dual antiplatelet therapy in acute ischemic stroke.急性缺血性脑卒中的双联抗血小板治疗。
Curr Atheroscler Rep. 2015 Jul;17(7):37. doi: 10.1007/s11883-015-0515-8.
7
Systematic Review and Meta-analysis of Dual Versus Single Antiplatelet Therapy in Carotid Interventions.颈动脉介入治疗中双重抗血小板治疗与单一抗血小板治疗的系统评价和荟萃分析
Eur J Vasc Endovasc Surg. 2017 Jan;53(1):53-67. doi: 10.1016/j.ejvs.2016.10.011. Epub 2016 Nov 26.
8
Dual antiplatelet therapy with clopidogrel and aspirin after ischemic stroke: A review of the evidence.缺血性卒中后氯吡格雷与阿司匹林联合抗血小板治疗：证据综述
Am J Health Syst Pharm. 2015 Oct 1;72(19):1623-9. doi: 10.2146/ajhp140804.
9
New opportunities to optimize antithrombotic therapy for secondary stroke prevention.优化抗血栓治疗以预防二级卒中的新机遇。
Int J Stroke. 2019 Apr;14(3):220-222. doi: 10.1177/1747493019828548. Epub 2019 Feb 6.
10
Homocysteine Level Predicts Response to Dual Antiplatelet in Women With Minor Stroke or Transient Ischemic Attack: Subanalysis of the CHANCE Trial.同型半胱氨酸水平预测女性小卒中或短暂性脑缺血发作患者对双联抗血小板治疗的反应：CHANCE 试验的亚组分析。
Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):839-846. doi: 10.1161/ATVBAHA.119.313741. Epub 2020 Jan 16.
引用本文的文献
1
Association between neurological deterioration and outcomes in patients with stroke.中风患者神经功能恶化与预后之间的关联。
Ann Transl Med. 2020 Jan;8(1):4. doi: 10.21037/atm.2019.12.36.
2
Case Series about the Changed Antiplatelet Protocol for Carotid Endarterectomy in a Teaching Hospital: More Patients with Complications?教学医院中颈动脉内膜切除术抗血小板方案改变的病例系列：并发症患者更多？
Surg J (N Y). 2018 Nov 5;4(4):e220-e225. doi: 10.1055/s-0038-1675566. eCollection 2018 Oct.
本文引用的文献
1
Clopidogrel With Aspirin in Acute Minor Stroke or Transient Ischemic Attack (CHANCE) Trial: One-Year Outcomes.氯吡格雷联合阿司匹林治疗急性小卒中或短暂性脑缺血发作（CHANCE）试验：一年结果。
Circulation. 2015 Jul 7;132(1):40-6. doi: 10.1161/CIRCULATIONAHA.114.014791. Epub 2015 May 8.
2
Risk-benefit profile of long-term dual- versus single-antiplatelet therapy among patients with ischemic stroke: a systematic review and meta-analysis.缺血性脑卒中患者长期双联与单联抗血小板治疗的获益-风险特征：系统评价和荟萃分析。
Ann Intern Med. 2013 Oct 1;159(7):463-70. doi: 10.7326/0003-4819-159-7-201310010-00006.
3
Cytochrome CYP2C19 polymorphism and risk of adverse clinical events in clopidogrel-treated patients: a meta-analysis based on 23,035 subjects.细胞色素 CYP2C19 多态性与氯吡格雷治疗患者不良临床事件风险的关系：基于 23035 例患者的荟萃分析。
Arch Cardiovasc Dis. 2013 Oct;106(10):517-27. doi: 10.1016/j.acvd.2013.06.055. Epub 2013 Sep 27.
4
Early dual versus mono antiplatelet therapy for acute non-cardioembolic ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis.急性非心源性缺血性卒中和短暂性脑缺血发作的早期双联与单联抗血小板治疗：一项更新的系统评价和荟萃分析。
Circulation. 2013 Oct 8;128(15):1656-66. doi: 10.1161/CIRCULATIONAHA.113.003187. Epub 2013 Sep 12.
5
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design.新型短暂性脑缺血发作和小面积缺血性卒中（POINT）试验中的血小板导向抑制：原理与设计。
Int J Stroke. 2013 Aug;8(6):479-83. doi: 10.1111/ijs.12129.
6
Clopidogrel with aspirin in acute minor stroke or transient ischemic attack.氯吡格雷联合阿司匹林治疗急性小卒中或短暂性脑缺血发作。
N Engl J Med. 2013 Jul 4;369(1):11-9. doi: 10.1056/NEJMoa1215340. Epub 2013 Jun 26.
7
Effect of addition of clopidogrel to aspirin on stroke incidence: Meta-analysis of randomized trials.氯吡格雷联合阿司匹林对中风发病率的影响：随机试验的荟萃分析。
Int J Stroke. 2015 Jul;10(5):686-91. doi: 10.1111/ijs.12050. Epub 2013 May 22.
8
Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.氯吡格雷联合阿司匹林治疗近期腔隙性脑梗死患者的效果。
N Engl J Med. 2012 Aug 30;367(9):817-25. doi: 10.1056/NEJMoa1204133.
9
Dual or mono antiplatelet therapy for patients with acute ischemic stroke or transient ischemic attack: systematic review and meta-analysis of randomized controlled trials.双联或单联抗血小板治疗急性缺血性卒中和短暂性脑缺血发作患者：随机对照试验的系统评价和荟萃分析。
Stroke. 2012 Apr;43(4):1058-66. doi: 10.1161/STROKEAHA.111.637686. Epub 2012 Jan 26.
10
The CYP2C19*17 allele is associated with better platelet response to clopidogrel in patients admitted for non-ST acute coronary syndrome.CYP2C19*17等位基因与因非ST段急性冠状动脉综合征入院患者对氯吡格雷的血小板反应更好相关。
J Thromb Haemost. 2009 Aug;7(8):1409-11. doi: 10.1111/j.1538-7836.2009.03500.x. Epub 2009 May 30.
Zotero 插件